Ellevest Inc’s Collegium Pharmaceutical COLL Stock Holding History

Ellevest Inc’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9	Closed	-$216	–	616
2023 Q1	$216	Buy	+9	New	+$239	﹤0.01%	1763

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Ellevest Inc's COLL Position: Q2 2023 in Review

Ellevest Inc sold out of Collegium Pharmaceutical (COLL) in Q2 2023, closing a stake of 9 shares — an estimated $216 sold.

Ellevest Inc first reported a position in COLL in Q1 2023 and held it in 1 quarter. The position peaked at $216 in Q1 2023. 178 funds tracked by Wall St. Rank hold COLL as of Q2 2023.

Ellevest Inc reported no remaining Collegium Pharmaceutical position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 9 Collegium Pharmaceutical shares in Q2 2023, an estimated $216.
Ellevest Inc first reported a position in Collegium Pharmaceutical in Q1 2023 and held it in 1 quarter.
Ellevest Inc's Collegium Pharmaceutical position peaked at $216 in Q1 2023.
178 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.